article · 2008
Impact of Gene Expression Profiling Tests on Breast Cancer Outcomes
Oncotype DX is furthest along the validation pathway, with strong retrospective evidence that it predicts distant spread and chemotherapy benefit to a clinic...
72 citationsDOI: https://doi.org/10.23970/ahrqepcerta160Open access